Growing medical marijuana is big business in Canada
An hour's drive south of Canada's capital, past snow-covered pine forests and farmland, Chuck Rifici is growing marijuana at an old Hershey's factory.
Feb 16, 2014
0
0
An hour's drive south of Canada's capital, past snow-covered pine forests and farmland, Chuck Rifici is growing marijuana at an old Hershey's factory.
Feb 16, 2014
0
0
Swiss pharmaceutical giant Novartis said Tuesday it is reviewing the future of its generic medicine division Sandoz, with all options on the table—including spinning it off.
Oct 26, 2021
0
23
US drugs giant Pfizer wants a blockbuster merger with British rival AstraZeneca that will fuel cancer research, revealing on Monday that an informal approach worth almost $100 billion had been rejected.
Apr 28, 2014
0
0
India's largest biotechnology firm, Biocon, and US pharmaceutical giant Pfizer said Tuesday they would scrap a joint plan to sell insulin products, sending Biocon's shares plunging.
Mar 13, 2012
0
0
With the legalization of recreational marijuana looming in Canada, therapeutic producer Aurora said Monday it was acquiring rival MedReleaf Corp. in a huge deal set to create a giant company.
May 14, 2018
0
3
When Canada legalized recreational marijuana in October, it emerged as the world leader in the industry—and U.S. companies are scrambling to get in on the action. Uruguay may have been the first country to legalize pot, ...
Dec 7, 2018
0
1
Shares in British pharmaceutical group GlaxoSmithKline and French peer Sanofi jumped Wednesday after a US court dismissed claims that heartburn drug Zantac caused cancer.
Dec 7, 2022
0
5
A private firm in Britain was given the green light Thursday to take over the management of a debt-ridden state hospital, in the country's first such deal.
Nov 10, 2011
0
0
U.S. drugmaker Perrigo agreed Monday to buy Ireland's Elan for $8.6 billion in a deal that should allow the rapidly growing company to reduce its tax bill and boost its royalty stream.
Jul 29, 2013
0
0
British consumer health giant Reckitt Benckiser announced Thursday it will pay up to $1.4 billion (1.2 billion euros) to settle a dispute with US authorities over the sale and marketing of an opioid addiction treatment.
Jul 11, 2019
0
1